ABSTRACT
Myopia is a leading cause of visual impairment and blindness worldwide. However, a safe and accessible approach for myopia control and prevention is currently unavailable. Here, we investigated the therapeutic effect of dietary supplements of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) on myopia progression in animal models and on decreases in choroidal blood perfusion (ChBP) caused by near work, a risk factor for myopia in young adults. We demonstrated that daily gavage of ω-3 PUFAs (300 mg docosahexaenoic acid [DHA] plus 60 mg eicosapentaenoic acid [EPA]) significantly attenuated the development of form deprivation myopia in guinea pigs and mice, as well as of lens-induced myopia in guinea pigs. Peribulbar injections of DHA also inhibited myopia progression in form-deprived guinea pigs. The suppression of myopia in guinea pigs was accompanied by inhibition of the "ChBP reduction-scleral hypoxia cascade." Additionally, treatment with DHA or EPA antagonized hypoxia-induced myofibroblast transdifferentiation in cultured human scleral fibroblasts. In human subjects, oral administration of ω-3 PUFAs partially alleviated the near-work-induced decreases in ChBP. Therefore, evidence from these animal and human studies suggests ω-3 PUFAs are potential and readily available candidates for myopia control.
Subject(s)
Fatty Acids, Omega-3/administration & dosage , Myopia/prevention & control , Administration, Oral , Animals , Cell Transdifferentiation , Cells, Cultured , Choroid/blood supply , Dietary Supplements , Disease Models, Animal , Disease Progression , Docosahexaenoic Acids/administration & dosage , Eicosapentaenoic Acid/administration & dosage , Guinea Pigs , Humans , Hypoxia/diet therapy , Hypoxia/physiopathology , Hypoxia/prevention & control , Mice , Myofibroblasts/pathology , Myopia/diet therapy , Myopia/physiopathology , Young AdultABSTRACT
Stickler's syndrome is an autosomal dominant inherited disorder of connective tissue related to incorrect collagen structure. The changes include ocular, hearing, and joint and bone abnormalities. We present a case of 6-years-old patient with Stickler's syndrome, with characteristic features.
Subject(s)
Connective Tissue Diseases/complications , Myopia/congenital , Myopia/diet therapy , Child , Humans , Male , SyndromeABSTRACT
Anthocyanins are one type of flavonoid phytopigment. Although the role of anthocyanins as a functional food factor remains relatively less established than that of other flavonoids, progress in this area has been made at the molecular level in recent years. This review discusses the potential health benefits of plant-derived anthocyanin-rich foods, with a focus on the role of anthocyanins in obesity control, diabetes control, cardiovascular disease prevention, and improvement of visual and brain functions, areas that have attracted much attention. Such health benefits are not necessarily derived from the antioxidant effect of anthocyanins, but in fact are produced by currently unestablished chemical properties beyond the antioxidant capacity of the molecules. However, a better understanding of the physiological functionality of anthocyanins remains to be elucidated. It is desirable, therefore, to clarify the molecular type and composition of the anthocyanins that confer specific health benefits and to conduct further investigation into the underlying molecular mechanisms. The pharmacological actions of anthocyanins could not be fully established without knowledge on the effects of treatment of anthocyanins alone, the effects of non-anthocyanin components, and the possible interactions between anthocyanin and non-anthocyanin species.
Subject(s)
Anthocyanins/pharmacology , Diet , Plants/chemistry , Aging/physiology , Anthocyanins/pharmacokinetics , Antioxidants/pharmacology , Brain/drug effects , Brain/physiology , Cardiovascular Diseases/prevention & control , Diabetes Mellitus/metabolism , Diabetes Mellitus/prevention & control , Food , Humans , Myopia/diet therapy , Obesity/diet therapy , Obesity/prevention & controlABSTRACT
We present a case of acute accommodation insufficiency after oral ingestion of glybenclamide. The symptom diminished after the drug was discontinued. Such an adverse effect has been described in association with other drugs but previously not with hypoglycemic agents.